ASP2453   Click here for help

GtoPdb Ligand ID: 11839

Compound class: Synthetic organic
Comment: ASP2453 is an oral, covalent inhibitor of the mutant KRASG12C protein [1]. It was developed as a potential therapeutic agent for cancers that are KRASG12C positive. ASP2453 is selective for KRASG12C and has no effect on wild-type KRAS protein functions.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 14
Topological polar surface area 105.7
Molecular weight 746.38
XLogP 10.35
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COCCCC1CCC(CC1)Oc1nc(N2CCC3(CC2)CN(C3)C(=O)C=C)c2c(n1)c(OCC(F)(F)F)c(c(c2)C1CC1)c1c(C)ccc2c1cn[nH]2
Isomeric SMILES COCCCC1CCC(CC1)Oc1nc(N2CCC3(CN(C3)C(=O)C=C)CC2)c2cc(C3CC3)c(c(OCC(F)(F)F)c2n1)c1c2cn[nH]c2ccc1C
InChI InChI=1S/C41H49F3N6O4/c1-4-33(51)50-22-40(23-50)15-17-49(18-16-40)38-30-20-29(27-10-11-27)35(34-25(2)7-14-32-31(34)21-45-48-32)37(53-24-41(42,43)44)36(30)46-39(47-38)54-28-12-8-26(9-13-28)6-5-19-52-3/h4,7,14,20-21,26-28H,1,5-6,8-13,15-19,22-24H2,2-3H3,(H,45,48)
InChI Key YNLGBBXDUCMNPY-UHFFFAOYSA-N
References
1. Nakayama A, Nagashima T, Nishizono Y, Kuramoto K, Mori K, Homboh K, Yuri M, Shimazaki M. (2022)
Characterisation of a novel KRAS G12C inhibitor ASP2453 that shows potent anti-tumour activity in KRAS G12C-mutated preclinical models.
Br J Cancer, 126 (5): 744-753. [PMID:34795410]